ANDA 40811, held by Renew Pharms. Indocyanine Green.
As of Nov 16, 2026, ANDA 40811 (Indocyanine Green), held by Renew Pharms, was first approved by FDA on Nov 21, 2007, with 2 approved supplements and 0 published complete response letters.
Indocyanine Green for Injection USP is indicated: Indocyanine Green for Injection USP a tricarbocyanine dye, is indicated:
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 21, 2007 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Indocyanine Green25MG/VIAL · injectable;injection | Indocyanine Green | Rx |
| Sep 29, 2020 | Supplement 6Labeling · Standard review | Approved | None posted |
| Feb 11, 2008 | Supplement 2Labeling | Approved | None posted |
| Nov 21, 2007 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters